Encompass Health Corporation (EHC)

Market Cap	12.21B +2.2%
Revenue (ttm)	6.21B +9.5%
Net Income	619.40M +18.8%
EPS	6.13 +19.9%
Shares Out	98.65M
PE Ratio	20.16
Forward PE	19.41
Dividend	$0.84 (0.68%)
Ex-Dividend Date	Oct 1, 2026

Volume	268,833
Open	123.53
Previous Close	123.55
Day's Range	122.52 - 123.93
52-Week Range	92.77 - 127.99
Beta	0.60
Analysts	Strong Buy
Price Target	148.17 (+19.73%)
Earnings Date	Aug 5, 2026

About EHC

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary cond...

• Industry: Medical Care Facilities
• Sector: Healthcare
• IPO Date: Sep 30, 1986
• Employees: 42,300
• Stock Exchange: NYSE
• Ticker Symbol: EHC
• Website: https://www.encompasshealth.com

Financial Performance

In 2025, Encompass Health's revenue was $5.94 billion, an increase of 10.46% compared to the previous year's $5.37 billion. Earnings were $564.70 million, an increase of 24.69%.

Analyst Summary

According to 13 analysts, the average rating for EHC stock is "Strong Buy." The 12-month stock price target is $148.17, which is an increase of 19.73% from the latest price.

Price Target

$148.17

(19.73% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Aug 14, 2026

Data Sources Report a data error